Gliclazide 21187-98-4 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-08
Product Details
- Product NameGliclazide
- CAS No.21187-98-4
- EINECS No.244-260-5
- MFC15H21N3O3S
- MW323.41
- Appearancepowderwhite
- Melting point 163-169 °C (lit.)
- storage temp. 2-8°C
- density 1.2205 (rough estimate)
Company Profile Introduction
Kreative, which started with one product, today has a portfolio of over 11 products. All of our products were developed by our in-house R&D team. Kreative continues to invest in R&D to develop products for which we can become the supplier of choice for the regulated and quality conscious markets.
These products are exported to regulated markets like USA and Europe and quality conscious customers in markets like Russia, Singapore, Brazil, Taiwan, Korea, etc. Kreative is proud to be the API supplier to some of the world’s largest pharmaceutical companies including Boehringer Ingelheim, Abbott, Actavis, Adcock, Sun Pharmaceuticals, Dr. Reddy’s, Emcure, Cipla, Zydus Cadila, Aurobindo, etc.
Supplier other products
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- 21187-98-4 GLICLAZIDE BP 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- AKASH PHARMA EXPORTS
- Gliclazide 99%
- Inquiry
- 2024-05-16
-
VIP1年
- Molsyns Research
- 21187-98-4 Gliclazide Reference Standard 98%
- Inquiry
- 2024-04-01
-
VIP1年
- Shankus Pharmaceuticals
- Gliclazide 21187-98-4 98%
- Inquiry
- 2024-03-26
-
VIP1年
- Harika Drugs Pvt Ltd
- Gliclazide 21187-98-4 99%
- Inquiry
- 2024-03-23
-
VIP1年
- Heer Pharma Pvt Ltd
- Gliclazide 21187-98-4 99%
- Inquiry
- 2024-03-23
-
VIP1年
- Granules India Limited
- Gliclazide 21187-98-4 99%
- Inquiry
- 2024-03-22
-
VIP1年
- Apionex Pharma Pvt Ltd
- 21187-98-4 Gliclazide 98%
- Inquiry
- 2024-03-20
-
VIP1年
- Sibram Pharmaceutical
- Gliclazide 99%
- Inquiry
- 2024-03-16
-
VIP1年
- Cadchem Laboratories Limited
- Gliclazide 98%
- Inquiry
- 2024-03-06
- Since:2021-02-01
- Address: Plot No.1306, Road No.65, Jubilee Hills, Hyderabad, Telangana-500 033, India.
INQUIRY